🇺🇸 FDA
Patent

US 11612580

Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions

granted A61KA61K31/06A61K31/136

Quick answer

US patent 11612580 (Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions) held by The Board of Regents of the University of Texas System expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/06, A61K31/136, A61K31/192, A61K31/24